Neurological manifestations of coronavirus infections: role of angiotensin-converting enzyme 2 in COVID-19.
Negin ParsamaneshAiyoub PezeshgiMina HemmatiMaryam JameshoraniEhsan SabooryPublished in: The International journal of neuroscience (2021)
The therapeutic possibilities of ACE2 antibody, ACE2-derived peptides, and small molecule blockers of ACE2 include a receptor-binding domain blocking approach. Hence, future studies of ACE2 may be very helpful in discovering a therapy for SARS-CoV-2.